The State of Robotic Partial Nephrectomy: Operative, Functional, and Oncological Outcomes From A Robust

Shirin Razdan1, Kennedy E Okhawere1, Burak Ucpinar1

  • 1Department of Urology, Icahn School of Medicine at Mount Sinai, New York, NY.

Urology
|January 2, 2023
PubMed
Abstract

Insights

Robotic partial nephrectomy (RPN) outcomes were analyzed in 2836 patients. Lower BMI, smaller tumor size, and lower complexity predict trifecta achievement in robotic kidney cancer surgery.

Area of Science:

  • Urology
  • Robotic Surgery
  • Oncology

Background:

  • Robotic partial nephrectomy (RPN) is a key procedure for kidney cancer.
  • Assessing RPN outcomes is crucial for surgical planning and patient counseling.

Purpose of the Study:

  • To evaluate surgical, functional, and oncological outcomes of RPN.
  • To identify predictors of trifecta achievement in robotic renal surgery.

Main Methods:

  • Analysis of a prospectively maintained multi-institutional database of 2836 patients undergoing RPN for localized kidney cancer (2018-2022).
  • Inclusion of data from 9 high-volume surgeons, examining demographic, tumor, operative, functional, and oncological outcomes.

Main Results:

  • RPN demonstrated low intraoperative (2.68%) and 30-day major complication rates (3.24%).
  • Lower tumor complexity correlated with shorter operative time, less blood loss, reduced ischemia, fewer complications, and better renal function preservation.
  • Lower BMI, smaller tumor size, lower complexity, and higher baseline eGFR were significant predictors of trifecta achievement.

Conclusions:

  • Patient BMI, baseline eGFR, and tumor characteristics (size, complexity) are key predictors of trifecta achievement.
  • Patients with complex tumors face higher risks of complications and renal function decline post-RPN.